Get the Stockscreener App
2.60
1.01%
+0.03
Mersana Therapeutics Inc Stock (MRSN) Forecast
The Mersana Therapeutics Inc (MRSN) stock price forecast for the next 30 days is generally negative, with an average analyst price target of $1.1242, representing a -56.76% decrease from the current price of $2.60. The highest analyst price target is $1.4492, and the lowest is $0.7992.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month MRSN Price Target
Average 3.6472
(+40.28% Upside)
Is Mersana Therapeutics Inc (MRSN) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 32.82 | Neutral |
| STOCH(9,6) | 11.99 | Buy |
| STOCHRSI(14) | 30.30 | Neutral |
| MACD(12,26) | -0.3281 | Sell |
| ADX(14) | 24.16 | Neutral |
| William %R | -87.29 | Buy |
| CCI(14) | -95.92 | Neutral |
Buy: 2
Sell: 1
Neutral: 4
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
2.946
Sell
|
2.8315
Sell
|
| MA20 |
3.04
Sell
|
3.0836
Sell
|
| MA50 |
3.9356
Sell
|
3.5026
Sell
|
| MA100 |
3.7001
Sell
|
3.4694
Sell
|
| MA200 |
2.5636
Buy
|
3.5706
Sell
|
Buy: 1
Sell: 9
Neutral: 0
Summary: Sell
According to our latest analysis, MRSN could be considered a Strong Sell, with 17 technical analysis indicators signaling 3 Buy signals, 10 signaling Sell signals and 4 Neutral signals. This might not be a good time to consider opening new positions on MRSN, as trading bearish markets can be challenging and may result in losses.
- RSI (Relative Strength Index): The RSI(14) value of 32.82 indicates that MRSN is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 11.99 indicates that MRSN is oversold. This indicates that MRSN price is at or near the lowest level over a specified lookback period.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 30.3 indicates that MRSN is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- ADX (Average Directional Index): The ADX value of The ADX value of 24.16 suggests that there may be some movement in price, but it lacks strength or conviction.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -95.92 indicates that MRSN is still oversold but not to an extreme extent.
Long-term MRSN price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Mersana Therapeutics Inc financial reports and earnings history, Mersana Therapeutics Inc (MRSN) stock could reach $1.5913 by 2030, $1.2746 by 2040 and $6.6458 by 2050. See the projected annual prices until 2050 of the Mersana Therapeutics Inc stock below:
- Mersana Therapeutics Inc (MRSN) is expected to reach an average price of $1.8638 in 2035, with a high prediction of $2.2074 and a low estimate of $1.9738. This indicates an $-28.32% rise from the last recorded price of $2.60.
- Mersana Therapeutics Inc (MRSN) stock is projected to chart a bullish course in 2040, with an average price target of $1.2946, representing an $-50.21% surge from its current level. The forecast ranges from a conservative $1.5892 to a sky-high $1.2746.
- Our analysts predict Mersana Therapeutics Inc (MRSN) to jump -74.41% by 2045, soaring from $1.083 to an average price of $0.6654, potentially reaching $1.3048. While $1.083 is the low estimate, the potential upside is significant.
- Mersana Therapeutics Inc (MRSN) stock is expected to climb by 2050, reaching an average of $6.9358, a $166.76% jump from its current level. However, a wide range of estimates exists, with high and low targets of $6.6458 and $6.9942, respectively, highlighting the market's uncertainty.
Mersana Therapeutics Inc Stock (MRSN) Year by Year Forecast
Mersana Therapeutics Inc Stock (MRSN) Price Forecast for 2024
Our forecast for MRSN stock price in 2024 now indicates an average price target of $3.1714 with a high forecast of $6.2801 and a low forecast of $0.0628. The average prediction reflects an increase of +21.98% from the last recorded price of $2.60.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| June, 2024 | $1.0889 | $0.7992 | $1.4492 | -58.12% |
| July, 2024 | $0.6481 | $0.5631 | $1.3087 | -75.07% |
| August, 2024 | $0.5875 | $0.0628 | $0.738 | -77.40% |
| September, 2024 | $1.1582 | $0.6227 | $0.8882 | -55.46% |
| October, 2024 | $1.2439 | $1.3833 | $1.3024 | -52.16% |
| November, 2024 | $0.8596 | $1.1293 | $0.9694 | -66.94% |
| December, 2024 | $1.3248 | $0.34 | $1.6348 | -49.05% |
Mersana Therapeutics Inc Stock (MRSN) Price Forecast for 2025
Mersana Therapeutics Inc Stock (MRSN) is expected to reach an average price of $12.41 in 2025, with a high prediction of $24.01 and a low estimate of $0.8194. This indicates an +377.44% rise from the last recorded price of $2.60.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2025 | $2.469 | $0.8194 | $4.0793 | -5.04% |
| February, 2025 | $3.9084 | $2.2639 | $6.0987 | +50.32% |
| March, 2025 | $5.4278 | $3.7459 | $6.7778 | +108.76% |
| April, 2025 | $2.792 | $1.3423 | $6.5626 | +7.38% |
| May, 2025 | $6.0013 | $2.0817 | $7.2317 | +130.82% |
| June, 2025 | $7.2807 | $4.921 | $7.8257 | +180.03% |
| July, 2025 | $17.23 | $6.8055 | $20.67 | +562.88% |
| August, 2025 | $18.88 | $16.72 | $22.28 | +626.32% |
| September, 2025 | $17.60 | $16.36 | $21.17 | +577.06% |
| October, 2025 | $13.56 | $12.80 | $18.52 | +421.46% |
| November, 2025 | $16.00 | $13.41 | $24.01 | +515.28% |
| December, 2025 | $15.42 | $13.95 | $17.28 | +493.13% |
Mersana Therapeutics Inc Stock (MRSN) Price Forecast for 2026
The predicted value for Mersana Therapeutics Inc (MRSN) in 2026 is set at an average of $16.32. Estimates vary from a peak of $26.54 to a trough of $6.0987, indicating an +527.67% surge from the present price of $2.60.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $22.53 | $14.93 | $23.71 | +766.57% |
| February, 2026 | $23.19 | $19.84 | $24.14 | +791.93% |
| March, 2026 | $18.55 | $14.96 | $26.54 | +613.44% |
| April, 2026 | $17.74 | $15.47 | $21.86 | +582.45% |
| May, 2026 | $15.00 | $14.32 | $17.86 | +477.04% |
| June, 2026 | $13.33 | $12.58 | $15.60 | +412.79% |
| July, 2026 | $12.17 | $11.36 | $15.39 | +367.95% |
| August, 2026 | $12.47 | $11.34 | $12.91 | +379.47% |
| September, 2026 | $10.47 | $10.18 | $12.91 | +302.70% |
| October, 2026 | $10.02 | $7.9497 | $10.80 | +285.37% |
| November, 2026 | $11.56 | $8.4544 | $11.79 | +344.58% |
| December, 2026 | $7.0833 | $6.0987 | $12.44 | +172.43% |
Mersana Therapeutics Inc Stock (MRSN) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Mersana Therapeutics Inc (MRSN) is $4.1048, with a high forecast of $7.6972 and a low forecast of $0.5124. This indicates an +57.88% increase from the last price of $2.60.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $6.1226 | $5.7046 | $7.2981 | +135.49% |
| February, 2027 | $5.742 | $5.702 | $7.6972 | +120.85% |
| March, 2027 | $3.4462 | $2.5562 | $5.9568 | +32.55% |
| April, 2027 | $4.0156 | $3.1511 | $4.9307 | +54.45% |
| May, 2027 | $2.025 | $1.8553 | $3.9304 | -22.12% |
| June, 2027 | $1.9092 | $1.2795 | $2.8998 | -26.57% |
| July, 2027 | $1.7885 | $1.4988 | $2.284 | -31.21% |
| August, 2027 | $1.6679 | $1.5479 | $2.8931 | -35.85% |
| September, 2027 | $1.1721 | $0.5124 | $1.8727 | -54.92% |
| October, 2027 | $1.5615 | $0.7765 | $1.6215 | -39.94% |
| November, 2027 | $3.2809 | $1.6163 | $3.4459 | +26.19% |
| December, 2027 | $5.4751 | $2.6707 | $5.9251 | +110.58% |
Mersana Therapeutics Inc Stock (MRSN) Price Forecast for 2028
In 2028, Mersana Therapeutics Inc (MRSN) is projected to reach an average price of $4.4471, with a high projection of $7.7672 and a low estimate of $1.127. This indicates an +71.04% rise from the last price of $2.60.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $5.6744 | $4.9499 | $6.1848 | +118.25% |
| February, 2028 | $4.7038 | $4.019 | $6.2672 | +80.92% |
| March, 2028 | $5.828 | $4.2387 | $6.0287 | +124.15% |
| April, 2028 | $4.5174 | $4.0377 | $6.2229 | +73.75% |
| May, 2028 | $3.8016 | $3.4166 | $5.3469 | +46.22% |
| June, 2028 | $4.431 | $3.1313 | $4.521 | +70.42% |
| July, 2028 | $4.5503 | $4.3008 | $5.2703 | +75.01% |
| August, 2028 | $2.6946 | $2.5646 | $4.7302 | +3.64% |
| September, 2028 | $2.5739 | $2.0042 | $3.0594 | -1.00% |
| October, 2028 | $5.2933 | $1.7835 | $5.4933 | +103.59% |
| November, 2028 | $5.8975 | $4.9877 | $6.5081 | +126.83% |
| December, 2028 | $1.4469 | $1.127 | $7.7672 | -44.35% |
Mersana Therapeutics Inc Stock (MRSN) Price Forecast for 2029
The 2029 price forecast for Mersana Therapeutics Inc Stock (MRSN) is $2.3514 on average, with a high prediction of $4.6452 and a low estimate of $0.0576. This represents an -9.56% decrease from the previous price of $2.60.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $0.5939 | $0.6489 | $2.1062 | -77.16% |
| February, 2029 | $0.5895 | $0.6395 | $0.5441 | -77.33% |
| March, 2029 | $0.3602 | $0.5102 | $0.5899 | -86.15% |
| April, 2029 | $0.2108 | $0.5308 | $0.4355 | -91.89% |
| May, 2029 | $0.5266 | $0.376 | $0.4612 | -79.75% |
| June, 2029 | $0.1828 | $0.2469 | $0.3979 | -92.97% |
| July, 2029 | $0.6222 | $0.0576 | $0.6922 | -76.07% |
| August, 2029 | $1.4864 | $0.417 | $1.9018 | -42.83% |
| September, 2029 | $2.1357 | $1.4812 | $2.7849 | -17.86% |
| October, 2029 | $3.0699 | $2.0606 | $4.6452 | +18.07% |
| November, 2029 | $1.6393 | $1.5693 | $3.1798 | -36.95% |
| December, 2029 | $0.355 | $1.03 | $1.9938 | -86.35% |
Mersana Therapeutics Inc Stock (MRSN) Price Forecast for 2030
Mersana Therapeutics Inc Stock (MRSN) is expected to reach an average price of $2.2485 in 2030, with a high forecast of $4.2108 and a low forecast of $0.2861. This signifies an -13.52% decrease from the last price of $2.60.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $2.1516 | $1.3597 | $1.5913 | -17.25% |
| February, 2030 | $1.9428 | $1.9625 | $1.8328 | -25.28% |
| March, 2030 | $2.5741 | $2.0732 | $2.2141 | -1.00% |
| April, 2030 | $3.3954 | $2.8844 | $3.2954 | +30.59% |
| May, 2030 | $4.2269 | $3.7757 | $4.2108 | +62.57% |
| June, 2030 | $3.8682 | $4.1382 | $4.1079 | +48.78% |
| July, 2030 | $2.4798 | $3.2198 | $3.8488 | -4.62% |
| August, 2030 | $1.241 | $1.971 | $1.8201 | -52.27% |
| September, 2030 | $0.1723 | $0.512 | $1.2387 | -93.37% |
| October, 2030 | $2.1861 | $0.5426 | $3.2774 | -15.92% |
| November, 2030 | $0.3849 | $0.5551 | $3.9855 | -85.20% |
| December, 2030 | $0.3114 | $0.2861 | $1.1342 | -88.02% |
3.78%
0.67%
Cap:
|
Volume (24h):